Phosphodiesterase inhibitors. Part 6: Design, synthesis, and structure–activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity

References

Page 1

	Year	Citations
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure Milton Packer, Joseph R. Carver, Richard J. Rodeheffer, New England Journal of Medicine	1991	2.2K
Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial Klaus F. Rabe, Eric Bateman, Denis O’Donnell, The Lancet AsthmaInflammationAntifibrotic TherapyAnti-inflammatoryInflammatory Lung Disease	2005	466
Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases G.L. Card, B.P. England, Yoshihisa Suzuki, Structure Drug TargetBiochemistryMedicineMechanism Of ActionStructural Basis	2004	425
Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. Theodore J. Torphy, Bradley J. Undem, L B Cieslinski, Journal of Pharmacology and Experimental Therapeutics	1993	165
The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family Lucien C.D. Gibson, Stuart F. Hastings, Ian McPhee, European Journal of Pharmacology Human PhosphodiesteraseInhibitory ProfileBiochemistryCellular EnzymologyMedicine	2006	146
Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors J. de Boer, Alison J. Philpott, Ronald G.M. van Amsterdam, British Journal of Pharmacology AsthmaPharmaceutical SciencePhosphodiesterase IsoenzymesHuman Bronchial CyclicPde Iv	1992	129
The Pharmacology of Two Novel Long-Acting Phosphodiesterase 3/4 Inhibitors, RPL554 [9,10-Dimethoxy-2(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2 H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-Dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4 H-pyrimido[6,1-a]isoquinolin-4-one] Victoria Boswell‐Smith, Domenico Spina, Alec W. Oxford, Journal of Pharmacology and Experimental Therapeutics	2006	106
Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Sunanda G. Dastidar, Deepa Rajagopal, Abhijit Ray PubMed InflammationAsthmaRheumatologyPde4 InhibitorsAnti-inflammatory	2007	105
Role of p38 MAP kinase in LPS‐induced airway inflammation in the rat El‐Bdaoui Haddad, Mark A. Birrell, Kerryn McCluskie, British Journal of Pharmacology	2001	88
The effect of selective and non‐selective phosphodiesterase inhibitors on allergen‐ and leukotriene C<sub>4</sub>‐induced contractions in passively sensitized human airways D. Schmidt, N. Watson, Gordon Dent, British Journal of Pharmacology	2000	84

Page 1